Tulipano Stephen J

Average Profitability
0.98%
Insider Buys Quantity
1
Insider Buys Sum
$29,997.00
Insider Sells Quantity
6
Insider Sells Sum
$4.52M

Insider Activity of Tulipano Stephen J

According to the SEC Form 4 filings, Tulipano Stephen J, being in a position of

  1. CFO at Stoke Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 4116 shares for $25,102,
    over all time since 2020-11-02, has bought 0 shares, and sold 104116 shares for $4.52M.

The largest purchase of all time was on 2017-02-17 and amounted to 6666 shares of Aldeyra Therapeutics, Inc. for $29,997.

The largest sale of all time was on 2021-02-22 and amounted to 25000 shares of Stoke Therapeutics, Inc. for $1.47M.

Biography of Tulipano Stephen J

No biography is available at this moment.

2024-03-19SaleStoke Therapeutics, Inc.
STOK
CFO
4,116
0.0097%
$6.10$25,102+129.98%
2021-02-23SaleStoke Therapeutics, Inc.
STOK
CFO
5,000
0.0135%
$58.60$292,992-54.39%
2021-02-22SaleStoke Therapeutics, Inc.
STOK
CFO
25,000
0.0688%
$58.92$1.47M-53.67%
2020-11-04SaleStoke Therapeutics, Inc.
STOK
CFO
33,268
0.1021%
$40.80$1.36M-9.65%
2020-11-03SaleStoke Therapeutics, Inc.
STOK
CFO
1,732
0.0052%
$39.84$68,998-8.8%
2020-11-02SaleStoke Therapeutics, Inc.
STOK
CFO
35,000
0.1035%
$37.25$1.3M-4.52%
2017-02-17PurchaseAldeyra Therapeutics, Inc.
ALDX
Chief Financial Officer
6,666
0.0426%
$4.50$29,997+0.98%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.